Publications

Results:
Category: Diane DiEuliis

Nov. 10, 2020

Security Implications of Emerging Biotechnologies

On April 26th, 2016, the Center for the Study of Weapons of Mass Destruction (CSWMD) at National Defense University held a workshop to explore “Security Implications of Emerging Biotechnologies.” Participants from government, NGOs and academia discussed opportunities and challenges of a new era of biotechnology.

Strategic Assessment 2020: Into a New Era of Great Power Competition Oct. 26, 2020

Weapons of Mass Destruction, Strategic Deterrence, and Great Power Competition

Mr. Paul Bernstein and others examine the role of nuclear, biological, and chemical weapons in great power competition in the 2020 Institute for National Strategic Studies (INSS) Strategic Assessment.

Strategic Assessment 2020: Into a New Era of Great Power Competition Oct. 26, 2020

Contemporary Great Power Technological Competitive Factors in the Fourth Industrial Revolution

In the latest Institute for National Strategic Studies (INSS) Strategic Assessment, Dr. T.X. Hammes and Dr. Diane DiEuliis explore how the convergence of new technologies is creating a fourth industrial revolution that will transform almost every aspect of 21st-century life.

April 27, 2020

Beyond 1918: Bringing Pandemic Response into the Present, and Future

The current pandemic gives us an opportunity to envision new tools, methods, and response policies that leverage emerging technologies, which, if adopted and prudently employed, would enable capability to far better predict, prepare, if not prevent the “next” biosecurity war, and not merely repeat the errors of the “last”. 

Jan. 22, 2020

Redefining Neuroweapons: Emerging Capabilities in Neuroscience and Neurotechnology

As global conflicts assume increasingly asymmetric and “gray zone” forms, the ability to employ current and newly developing techniques and tools of neurocognitive science to manipulate human thought and behavior must be viewed as a present and increasing challenge. DeFranco, DiEuliis, and Giordano examine how developments in neuroscience and technology (neuroS/T) make the brain sciences of growing value for operational use in warfare, intelligence, and national security…

Dec. 2, 2019

Synthetic Biology Industry Practices and Opportunities for Biosecurity and Potential Roles for the U.S. Government

This report summarizes discussions with industry representatives about the current and future structure of the synthetic biology industry, perspectives on potential misuse and vulnerabilities of synthetic biology tools and capabilities, and business practices to prevent misuse of tools and to protect industry assets.

Dec. 3, 2018

Biotechnology for the Battlefield: In Need of a Strategy

In her article, published on War on the Rocks, CSWMD Senior Research Fellow Dr. Diane DiEuliis discusses the need for a more cohesive strategy to harness the potential uses of biotechnology on the battlefield.

April 4, 2018

Biodata Risks and Synthetic Biology: A Critical Juncture

The tools of synthetic biology and the life sciences are rapidly advancing, as the ability to apply classical engineering to biological systems creates increasing possibilities for innovations in health and medicine, materials science, energy and agriculture

Nov. 3, 2017

Biosecurity Implications for the Synthesis of Horsepox, an Orthopoxvirus

This article examines the biosecurity and biodefense implications resulting from the recent creation of horsepox virus, a noncirculating (extinct) species of orthopoxvirus. Here we examine the technical aspects of the horsepox virus synthesis and conclude that orthopox synthesis experiments currently remain technically challenging—and will continue to be so, even once this work is published in the scientific literature.

Oct. 3, 2017

Options for Synthetic DNA Order Screening, Revisited

DNA synthesis is a valuable research tool in the design of new biological products for medicine and manufacturing, and the ability to chemically synthesize long tracts of DNA has allowed for the development of influenza vaccines and diagnostic tests.